dipyridamole has been researched along with Pulmonary Stenoses in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stern, H | 1 |
| Sauer, U | 1 |
| Locher, D | 1 |
| Bauer, R | 1 |
| Meisner, H | 1 |
| Sebening, F | 1 |
| Bühlmeyer, K | 1 |
1 other study available for dipyridamole and Pulmonary Stenoses
| Article | Year |
|---|---|
Left ventricular function assessed with echocardiography and myocardial perfusion assessed with scintigraphy under dipyridamole stress in pediatric patients after repair for anomalous origin of the left coronary artery from the pulmonary artery.
Topics: Child, Preschool; Coronary Vessel Anomalies; Dipyridamole; Echocardiography; Exercise Test; Female; | 1993 |